Exact Mass: 323.2590918

Exact Mass Matches: 323.2590918

Found 89 metabolites which its exact mass value is equals to given mass value 323.2590918, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N-Jasmonoylisoleucine

(2S,3S)-2-({1-hydroxy-2-[(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl]ethylidene}amino)-3-methylpentanoate

C18H29NO4 (323.20964740000005)


N-Jasmonoylisoleucine belongs to the class of organic compounds known as isoleucine and derivatives. Isoleucine and derivatives are compounds containing isoleucine or a derivative thereof resulting from the reaction of isoleucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-Jasmonoylisoleucine is an extremely weak basic (essentially neutral) compound (based on its pKa). N-Jasmonoylisoleucine is found in pulses. N-Jasmonoylisoleucine is isolated from Pinus mugo (dwarf mountain pine) and Vicia fab.

   
   

Linoleoyl ethanolamide

(9Z,12Z)-N-(2-Hydroxyethyl)octadeca-9,12-dien-1-amide

C20H37NO2 (323.2824142)


Linoleoyl ethanolamide inhibits arachidonoylethanolamide amidohydrolase. [HMDB] Linoleoyl ethanolamide inhibits arachidonoylethanolamide amidohydrolase.

   

Undeca-2,4,6-trienoylcarnitine

4-(trimethylazaniumyl)-3-(undeca-2,4,6-trienoyloxy)butanoate

C18H29NO4 (323.20964740000005)


Undeca-2,4,6-trienoylcarnitine is an acylcarnitine. More specifically, it is an undeca-2,4,6-trienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Undeca-2,4,6-trienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Undeca-2,4,6-trienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Undeca-2,5,8-trienoylcarnitine

4-(trimethylazaniumyl)-3-(undeca-2,5,8-trienoyloxy)butanoate

C18H29NO4 (323.20964740000005)


Undeca-2,5,8-trienoylcarnitine is an acylcarnitine. More specifically, it is an undeca-2,5,8-trienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Undeca-2,5,8-trienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Undeca-2,5,8-trienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4E,6E)-Undeca-4,6,9-trienoylcarnitine

4-(trimethylazaniumyl)-3-(undeca-4,6,9-trienoyloxy)butanoate

C18H29NO4 (323.20964740000005)


(4E,6E,9E)-Undeca-4,6,9-trienoylcarnitine is an acylcarnitine. More specifically, it is an (4E,6E,9E)-undeca-4,6,9-trienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4E,6E,9E)-Undeca-4,6,9-trienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (4E,6E,9E)-Undeca-4,6,9-trienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Undeca-3,5,7-trienoylcarnitine

4-(trimethylazaniumyl)-3-(undeca-3,5,7-trienoyloxy)butanoate

C18H29NO4 (323.20964740000005)


Undeca-3,5,7-trienoylcarnitine is an acylcarnitine. More specifically, it is an undeca-3,5,7-trienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Undeca-3,5,7-trienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Undeca-3,5,7-trienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(9E,12E)-N-(2-Hydroxyethyl)octadeca-9,12-dienamide

(9E,12E)-N-(2-Hydroxyethyl)octadeca-9,12-dienamide

C20H37NO2 (323.2824142)


   

Cicloprolol

1-{4-[2-(cyclopropylmethoxy)ethoxy]phenoxy}-3-[(propan-2-yl)amino]propan-2-ol

C18H29NO4 (323.20964740000005)


   
   
   
   
   
   
   
   

(+)-allopumiliotoxin 323B|(7S,8R,8aS,6E)-7,8-Dihydroxy-8-methyl-[(2R,4E,6S)-2,5-dimethyl-6-hydroxy-4-octenylidene]octahydroindolizidine|allopumiliotoxin 323B

(+)-allopumiliotoxin 323B|(7S,8R,8aS,6E)-7,8-Dihydroxy-8-methyl-[(2R,4E,6S)-2,5-dimethyl-6-hydroxy-4-octenylidene]octahydroindolizidine|allopumiliotoxin 323B

C19H33NO3 (323.2460308000001)


   
   
   
   
   

14,15-dehydro-holadienine

14,15-dehydro-holadienine

C22H29NO (323.2249024)


   
   

3alpha-(3,4-dihydroxymyrtanoyloxy)tropane|8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3,4-dihydroxy-6,6-dimethylbicyclo[3.1.1]heptan-2-carboxylate|bonabiline A

3alpha-(3,4-dihydroxymyrtanoyloxy)tropane|8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3,4-dihydroxy-6,6-dimethylbicyclo[3.1.1]heptan-2-carboxylate|bonabiline A

C18H29NO4 (323.20964740000005)


   

N-3-oxo-tetradec-7Z-enoyl-L-Homoserine lactone

N-3-oxo-tetradec-7Z-enoyl-L-Homoserine lactone

C18H29NO4 (323.20964740000005)


   

Jasmonic acid-isoleucine (JA-Ile)

Jasmonic acid-isoleucine (JA-Ile)

C18H29NO4 (323.20964740000005)


   

Linoleoyl ethanolamide

Linoleoyl ethanolamide

C20H37NO2 (323.2824142)


   
   
   

(7R,E)-8-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-4,7-dimethyloct-4-ene-2,3-diol

(7R,E)-8-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-4,7-dimethyloct-4-ene-2,3-diol

C19H33NO3 (323.2460308000001)


   

(7R,8R,E)-6-((2R,E)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizine-7,8-diol

(7R,8R,E)-6-((2R,E)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizine-7,8-diol

C19H33NO3 (323.2460308000001)


   

(7R,E)-8-((1S,Z)-1-hydroxyhexahydro-2H-quinolizin-3(4H)-ylidene)-4,7-dimethyloct-4-ene-2,3-diol

(7R,E)-8-((1S,Z)-1-hydroxyhexahydro-2H-quinolizin-3(4H)-ylidene)-4,7-dimethyloct-4-ene-2,3-diol

C19H33NO3 (323.2460308000001)


   

Linoleyl ethanolamide

(9Z,12Z)-N-(2-hydroxyethyl)octadeca-9,12-dienamide

C20H37NO2 (323.2824142)


   

N-3-oxo-tetradec-7(Z)-enoyl-L-Homoserine lactone

3-oxo-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-7-tetradecenamide

C18H29NO4 (323.20964740000005)


   

N-Jasmonoylisoleucine

3-methyl-2-(2-{3-oxo-2-[(2E)-pent-2-en-1-yl]cyclopentyl}acetamido)pentanoic acid

C18H29NO4 (323.20964740000005)


   

N-jasmonoyl-isoleucine

N-({(1R,2R)-3-Oxo-2-[(2Z)-Pent-2-En-1-Yl]cyclopentyl}acetyl)-L-Isoleucine

C18H29NO4 (323.20964740000005)


   

NAE 18:2

N-cis-9-cis-12-Octadecadienoylethanolamine

C20H37NO2 (323.2824142)


   

N,N-bis(2-hydroxyethyl)-N-methyldodecan-1-aminium chloride

N,N-bis(2-hydroxyethyl)-N-methyldodecan-1-aminium chloride

C17H38ClNO2 (323.2590918)


   

Bufetolol

Bufetolol

C18H29NO4 (323.20964740000005)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

Cicloprolol

1-[4-[2-(cyclopropylmethoxy)ethoxy]phenoxy]-3-(propan-2-ylamino)propan-2-ol

C18H29NO4 (323.20964740000005)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

   

tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3,6,7-tetrahydroazepine-1-carboxylate

tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3,6,7-tetrahydroazepine-1-carboxylate

C17H30BNO4 (323.226777)


   
   

tert-Butyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)carbamate

tert-Butyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)carbamate

C17H30BNO4 (323.226777)


   

Guaiapate

Guaiapate

C18H29NO4 (323.20964740000005)


C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent

   

p-ethoxybenzylidene p-heptylaniline

p-ethoxybenzylidene p-heptylaniline

C22H29NO (323.2249024)


   

3-Amino-3-(hydroxymethyl)-1-(4-octylphenyl)-1,4-butanediol

3-Amino-3-(hydroxymethyl)-1-(4-octylphenyl)-1,4-butanediol

C19H33NO3 (323.2460308000001)


   
   

4-Butoxybenzylidene-4-pentylaniline

4-Butoxybenzylidene-4-pentylaniline

C22H29NO (323.2249024)


   

Tris(2-(2-methoxyethoxy)ethyl)amine

Tris(2-(2-methoxyethoxy)ethyl)amine

C15H33NO6 (323.2307758)


   

N-({(1r,2s)-3-Oxo-2-[(2z)-Pent-2-En-1-Yl]cyclopentyl}acetyl)-L-Isoleucine

N-({(1r,2s)-3-Oxo-2-[(2z)-Pent-2-En-1-Yl]cyclopentyl}acetyl)-L-Isoleucine

C18H29NO4 (323.20964740000005)


   

N-(2-hydroxyethyl)octadeca-9,12-dienamide

N-(2-hydroxyethyl)octadeca-9,12-dienamide

C20H37NO2 (323.2824142)


   

4-[[Bis(2-hydroxyethyl)amino]methyl]-2,6-ditert-butylphenol

4-[[Bis(2-hydroxyethyl)amino]methyl]-2,6-ditert-butylphenol

C19H33NO3 (323.2460308000001)


   

Ethanaminium, N-[6-(diethylamino)-3H-xanthen-3-ylidene]-N-ethyl-, chloride

Ethanaminium, N-[6-(diethylamino)-3H-xanthen-3-ylidene]-N-ethyl-, chloride

C21H27N2O+ (323.2123272)


   
   

dihydromonacolin L carboxylate

dihydromonacolin L carboxylate

C19H31O4- (323.2222226)


A hydroxy monocarboxylic acid anion that is the conjugate base of dihydromonacolin L acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

N-[2-[3-oxo-2-(2Z)-2-penten-1-yl-cyclopentyl]acetyl]-L-isoleucine

N-[2-[3-oxo-2-(2Z)-2-penten-1-yl-cyclopentyl]acetyl]-L-isoleucine

C18H29NO4 (323.20964740000005)


   

(11Z,17Z)-14R-hydroxy-eicosa-11,17-dienoate

(11Z,17Z)-14R-hydroxy-eicosa-11,17-dienoate

C20H35O3- (323.258606)


   

4-methyl-2-[[2-[(1R,2R)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]pentanoic acid

4-methyl-2-[[2-[(1R,2R)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]pentanoic acid

C18H29NO4 (323.20964740000005)


   

(2S)-4-methyl-2-[[2-[3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]pentanoic acid

(2S)-4-methyl-2-[[2-[3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]pentanoic acid

C18H29NO4 (323.20964740000005)


   
   
   
   

(4E,6E)-Undeca-4,6,9-trienoylcarnitine

(4E,6E)-Undeca-4,6,9-trienoylcarnitine

C18H29NO4 (323.20964740000005)


   

(Z,Z)-dicyclopropyl-oxomycolate

(Z,Z)-dicyclopropyl-oxomycolate

C19H31O4- (323.2222226)


   

N-({(1R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetyl)-L-isoleucine

N-({(1R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetyl)-L-isoleucine

C18H29NO4 (323.20964740000005)


   

(15S)-hydroxy-(11Z,13E)-eicosadienoate

(15S)-hydroxy-(11Z,13E)-eicosadienoate

C20H35O3- (323.258606)


   

N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]acetamide

N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]acetamide

C19H33NO3 (323.2460308000001)


   

N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]propanamide

N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]propanamide

C19H33NO3 (323.2460308000001)


   

N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]butanamide

N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]butanamide

C19H33NO3 (323.2460308000001)


   

N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]pentanamide

N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]pentanamide

C19H33NO3 (323.2460308000001)


   
   

N-[(+)-7-isojasmonyl]-L-isoleucine

N-[(+)-7-isojasmonyl]-L-isoleucine

C18H29NO4 (323.20964740000005)


An L-isoleucine derivative resulting from the formal condensation of the carboxy group of (+)-7-isojasmonic acid with the amino group of L-isoleucine.

   

AEA(18:2)

AEA(18:2)

C20H37NO2 (323.2824142)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   

S3QEL-2

S3QEL-2

C19H25N5 (323.210985)


S3QEL-2, a suppressor of superoxide production from mitochondrial complex III, potently and selectively suppresses site IIIQo superoxide production (IC50=1.7 μM). S3QEL-2 does not affect oxidative phosphorylation, and normal electron flux. S3QEL-2 inhibits HIF-1α accumulation[1].

   

(1s,5r)-1-(butanoyloxy)-6,8-dimethyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

(1s,5r)-1-(butanoyloxy)-6,8-dimethyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

C18H29NO4 (323.20964740000005)


   

8-(8-hydroxy-8-methyl-hexahydroindolizin-6-ylidene)-4,7-dimethyloct-4-ene-2,3-diol

8-(8-hydroxy-8-methyl-hexahydroindolizin-6-ylidene)-4,7-dimethyloct-4-ene-2,3-diol

C19H33NO3 (323.2460308000001)


   

(2s,3r)-2-({1-hydroxy-2-[(1r,2s)-3-oxo-2-[(2z)-pent-2-en-1-yl]cyclopentyl]ethylidene}amino)-3-methylpentanoic acid

(2s,3r)-2-({1-hydroxy-2-[(1r,2s)-3-oxo-2-[(2z)-pent-2-en-1-yl]cyclopentyl]ethylidene}amino)-3-methylpentanoic acid

C18H29NO4 (323.20964740000005)


   

n-(1,3-dihydroxy-3-methyl-4-oxopentan-2-yl)-6,8-dimethyldeca-2,4,6-trienamide

n-(1,3-dihydroxy-3-methyl-4-oxopentan-2-yl)-6,8-dimethyldeca-2,4,6-trienamide

C18H29NO4 (323.20964740000005)


   

methyl 1-[(dimethylamino)methyl]-3a-hydroxy-5-isopropyl-7a-methyl-7-oxo-1,2,3,4-tetrahydroindene-4-carboxylate

methyl 1-[(dimethylamino)methyl]-3a-hydroxy-5-isopropyl-7a-methyl-7-oxo-1,2,3,4-tetrahydroindene-4-carboxylate

C18H29NO4 (323.20964740000005)


   

2-({1-hydroxy-2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]ethylidene}amino)-3-methylpentanoic acid

2-({1-hydroxy-2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]ethylidene}amino)-3-methylpentanoic acid

C18H29NO4 (323.20964740000005)